Back to Results
First PageMeta Content



LSE/AIM: VER A Revenue-Generating Pharmaceutical Company Funded to Self Sustainability The licensing deal with Tris Pharma in February 2012 dramatically accelerated Vernalis’ progression towards becoming a diversified,
Add to Reading List

Document Date: 2015-05-21 10:22:07


Open Document

File Size: 684,62 KB

Share Result on Facebook